NCT07495410

Brief Summary

This study will evaluate whether a 12-week physiotherapy and exercise program can improve physical function and quality of life in patients with Anderson-Fabry disease. Participants will complete assessments before and after the program. The intervention includes regular exercise sessions using body weight, resistance bands, and gradual increases in daily physical activity. The study is intended to determine whether a structured physiotherapy program is feasible and potentially beneficial for people living with Anderson-Fabry disease.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
25mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Oct 2025Jun 2028

Study Start

First participant enrolled

October 6, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 27, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

March 27, 2026

Status Verified

March 1, 2026

Enrollment Period

2.2 years

First QC Date

March 21, 2026

Last Update Submit

March 21, 2026

Conditions

Keywords

Fabry diseaseAnderson-Fabry diseasephysiotherapyexerciseexercise trainingrehabilitationphysical activityquality of lifefunctional capacitymuscle strength

Outcome Measures

Primary Outcomes (1)

  • Change in cardiorespiratory fitness

    Change in cardiorespiratory fitness assessed by ergospirometry before and after the 12-week targeted physiotherapy intervention.

    Baseline and after 12 weeks

Secondary Outcomes (8)

  • Change in muscle strength

    Baseline and after 12 weeks

  • Change in functional capacity measured by the 6-minute walk test

    Baseline and after 12 weeks

  • Change in functional performance measured by the 30-second chair stand test

    Baseline and after 12 weeks

  • Change in respiratory function

    Baseline and after 12 weeks

  • Change in health-related quality of life

    Baseline and after 12 weeks

  • +3 more secondary outcomes

Study Arms (1)

Physiotherapy intervention

EXPERIMENTAL

Participants will receive a 12-week targeted physiotherapy and exercise intervention consisting of 45-minute sessions performed three times per week and increasing number of daily steps. The program combines aerobic and strengthening exercise, including body weight exercises, resistance band training, and a gradual increase in daily step count.

Behavioral: Physiotherapy exercise programe

Interventions

A 12-week physiotherapy and exercise program consisting of 45-minute sessions performed three times per week and gradual increase in daily step count by approximately 10 percent every 2 weeks. The intervention combines aerobic and strengthening components, including body weight exercises and resistance band training, together with counting of daily steps. Adherence is monitored using exercise diaries and regular follow-up during therapy sessions.

Physiotherapy intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Anderson-Fabry disease
  • Age 18 years or older
  • Followed at a participating clinical center
  • Able to understand study procedures and provide informed consent
  • Clinically stable and considered suitable for participation in a physiotherapy and exercise program

You may not qualify if:

  • Acute deterioration in health status at the time of enrollment
  • Medical contraindication to exercise testing or participation in the exercise program
  • Severe comorbidity preventing safe participation in the intervention
  • Inability to comply with the study procedures or complete follow-up assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General University Hospital

Prague, 19800, Czechia

Location

MeSH Terms

Conditions

Fabry DiseaseMotor Activity

Condition Hierarchy (Ancestors)

SphingolipidosesLysosomal Storage Diseases, Nervous SystemBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCerebral Small Vessel DiseasesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolism, Inborn ErrorsLipidosesLipid Metabolism, Inborn ErrorsLysosomal Storage DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesLipid Metabolism DisordersBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All enrolled participants will receive the same 12-week exercise intervention. Outcomes will be assessed before and after the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Masters degree

Study Record Dates

First Submitted

March 21, 2026

First Posted

March 27, 2026

Study Start

October 6, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

June 30, 2028

Last Updated

March 27, 2026

Record last verified: 2026-03

Locations